Mags Tanev, our co-host here at Brains Byte Back, brings the second installment of her series The New Era of Psychedelics, exploring scientific research, therapies, and the potential benefits of psychedelic compounds and plant medicines in our societies.
In this episode, Tanev interviews Gaurav Dubey, a clinical biologist, and science blogger, to discuss research surrounding microdosing, the benefits of microdosing vs. other types of psychedelic use, and changing attitudes towards microdosing and psychedelics in our society.
Listen to this podcast on Spotify, Anchor, Apple Podcasts, Breaker, Google Podcasts, Stitcher, Overcast, Listen Notes, and Radio Public.
In addition to Dubey, Tanev also speaks with a psychedelics enthusiast with a high level of microdosing experience who wanted to keep his identity anonymous.
Construction is one of the world’s most complex industries to manage. Projects run late, costs…
Illegal immigration is the Trojan Horse of choice to deliver mandatory digital ID: perspective Using…
Since the launch of OpenAI’s ChatGPT in late 2022, use of artificial intelligence (AI) has…
Since its massification in the early 2020s, AI has been slowly integrated into sectors as…
The EU, UN, WEF, and G20 all call on stakeholders to mitigate the harmful effects…
Back in 2018, I wrote a story, To Kill an Outsourcing Bird. For my younger readers,…
View Comments